STAA
Staar Surgical Co.

1,485
Mkt Cap
$989.86M
Volume
1.86M
52W High
$30.81
52W Low
$14.69
PE Ratio
-10.17
STAA Fundamentals
Price
$19.90
Prev Close
$20.32
Open
$20.31
50D MA
$20.49
Beta
1.03
Avg. Volume
1.73M
EPS (Annual)
-$0.4114
P/B
2.78
Rev/Employee
$259,208.09
$997.57
Loading...
Loading...
News
all
press releases
STAAR Surgical Company (NASDAQ:STAA) Short Interest Update
STAAR Surgical Company (NASDAQ:STAA - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 13th, there was short interest totaling 5,735,019...
MarketBeat·11h ago
News Placeholder
More News
News Placeholder
Dentsply International (XRAY) Q4 Earnings Miss Estimates
Dentsply (XRAY) delivered earnings and revenue surprises of -3.57% and +4.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·3d ago
News Placeholder
STAAR Surgical Surpasses 4 Million ICLs Sold Globally, Reflecting Ongoing Shift Away from Laser-Based Vision Correction
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that more than 4 million...
Business Wire·4d ago
News Placeholder
STAAR Surgical (NASDAQ:STAA) Trading Up 8.4% - Here's What Happened
STAAR Surgical (NASDAQ:STAA) Shares Up 8.4% - Here's What Happened...
MarketBeat·6d ago
News Placeholder
Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?
MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.
Zacks·6d ago
News Placeholder
BrightSpring to Post Q4 Earnings: What's in Store for the Stock?
BTSG is set to report Q4 earnings with strong pharmacy growth, steady provider gains and improving margins.
Zacks·6d ago
News Placeholder
STAAR Surgical to Host Fourth Quarter and Fiscal Year 2025 Earnings Conference Call and Webcast on March 3, 2026
STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer Lenses (EVO ICL) for vision correction, today announced that it will release...
Business Wire·6d ago
News Placeholder
DENTSPLY SIRONA to Post Q4 Earnings: What's in Store for the Stock?
XRAY gears up for Q4 results amid U.S. weakness, tariff headwinds and a lowered outlook as investors watch for signs of stabilization.
Zacks·7d ago
News Placeholder
Solventum to Post Q4 Earnings: What's in Store for the Stock?
SOLV readies Q4 results amid solid momentum, tariff headwinds, and M&A focus as investors watch margins and growth trends closely.
Zacks·7d ago
News Placeholder
STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years
STAAR Surgical jumps 8% after the FDA expands the EVO ICL age range to 21-60, backed by strong safety data and rising demand for LASIK alternatives.
Zacks·11d ago
<
1
2
...
>

Latest STAA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.